Dr. Agarwal's Health Care Limited (BOM:544350)

Market Cap	126.13B
Revenue (ttm)	17.11B
Net Income (ttm)	834.60M
Shares Out	n/a
EPS (ttm)	2.78
PE Ratio	151.13
Forward PE	105.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,880
Average Volume	30,188
Open	400.05
Previous Close	399.80
Day's Range	387.00 - 401.40
52-Week Range	327.40 - 463.85
Beta	n/a
RSI	62.72
Earnings Date	Aug 8, 2025

About Dr. Agarwal's Health Care

Dr. Agarwal’s Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Health Services
• Founded: 2010
• Employees: 4,214
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544350

Financial Performance

In 2024, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.